SRTS (Sensus Healthcare) FFO


SRTS Sensus Healthcare Inc SRTS
76 GF Score
Price $2.92
GF Value $2.85
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sensus Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

SRTS
76GF Score
Sensus Healthcare Inc SRTS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sensus Healthcare (SRTS) Overvalued in 2026?

Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued. The current stock price of $2.92 is trading 2.5% above its estimated GF Value™ of $2.85. GuruFocus considers Sensus Healthcare to be Fairly Valued.

Key valuation signals for SRTS:

  • FFO:
  • GF Value™: $2.85 vs. price of $2.92 (2.5% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensus Healthcare Business Description

Other Exchanges 5TX:Germany
Address 851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
76GF Score

Get the complete analysis for SRTS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.92
Price
$2.85
GF Value